These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38709746)

  • 1. The efficacy and safety of MARS-PD: Meridian activation remedy system for Parkinson's disease-A single-center, assessor and statistician-blinded, parallel-group randomized, controlled trial protocol.
    Park MS; Park S; Kang JY; Jung IC; Yoo H
    PLoS One; 2024; 19(5):e0303156. PubMed ID: 38709746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Meridian Activation Remedy System for Alleviating Motor Symptoms in Parkinson's Disease: an Observational Study.
    Choi I; Park S; Lee SH; Seo JW; Seol IC; Kim YS; Park MS; Yoo H
    J Acupunct Meridian Stud; 2024 Apr; 17(2):55-68. PubMed ID: 38686429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gait Disturbance Improvement and Cerebral Cortex Rearrangement by Acupuncture in Parkinson's Disease: A Pilot Assessor-Blinded, Randomized, Controlled, Parallel-Group Trial.
    Jang JH; Park S; An J; Choi JD; Seol IC; Park G; Lee SH; Moon Y; Kang W; Jung ES; Cha JY; Kim CY; Kim S; Jung IC; Yoo H
    Neurorehabil Neural Repair; 2020 Dec; 34(12):1111-1123. PubMed ID: 33198568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial.
    Patterson CG; Joslin E; Gil AB; Spigle W; Nemet T; Chahine L; Christiansen CL; Melanson E; Kohrt WM; Mancini M; Josbeno D; Balfany K; Griffith G; Dunlap MK; Lamotte G; Suttman E; Larson D; Branson C; McKee KE; Goelz L; Poon C; Tilley B; Kang UJ; Tansey MG; Luthra N; Tanner CM; Haus JM; Fantuzzi G; McFarland NR; Gonzalez-Latapi P; Foroud T; Motl R; Schwarzschild MA; Simuni T; Marek K; Naito A; Lungu C; Corcos DM;
    Trials; 2022 Oct; 23(1):855. PubMed ID: 36203214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a combination of emotional freedom technique with acupuncture versus acupuncture alone to treat psychiatric symptoms in Parkinson's disease: A protocol for a randomized, assessor-blind, parallel-group clinical trial.
    Kang DH; Kim JY; Park YC; Yoo HR; Jung IC
    Medicine (Baltimore); 2023 May; 102(21):e33714. PubMed ID: 37233421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of acupuncture (Jin's three-needle) on motor symptoms and anxiety in patients with Parkinson's disease: protocol for a multicentre, randomised, assessor-blinded clinical trial.
    Liu X; Fan J; Leong II; Lu W; Zhang Y; Gong M; Zhuang L
    BMJ Open; 2024 Mar; 14(3):e081312. PubMed ID: 38548359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study.
    Carroll CB; Webb D; Stevens KN; Vickery J; Eyre V; Ball S; Wyse R; Webber M; Foggo A; Zajicek J; Whone A; Creanor S
    BMJ Open; 2019 Oct; 9(10):e029740. PubMed ID: 31594876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of robot-assisted gait training in patients with Parkinson's disease: study protocol for a randomized controlled trial.
    Kang MG; Yun SJ; Shin HI; Kim E; Lee HH; Oh BM; Seo HG
    Trials; 2019 Jan; 20(1):15. PubMed ID: 30616685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxibustion treatment for Parkinson's disease: study protocol for a randomized controlled trial.
    Wu C; Zhao L; Guo Y; Hao X; Fan Y; Wu P; Han J; Li Q; Wang X; Wang Q; Luo X; Zhu M
    BMC Complement Med Ther; 2023 Jun; 23(1):193. PubMed ID: 37303044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Wearable low-intensity pulsed Ultrasound treatment in the Movement disorder in Parkinson's disease (the SWUMP trial): protocol for a single-site, double-blind, randomized controlled trial.
    Zhong C; Guo N; Hu C; Ni R; Zhang X; Meng Z; Liu T; Ding S; Ding W; Zhao Y; Cao L; Zheng Y
    Trials; 2024 Apr; 25(1):275. PubMed ID: 38650028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of herbal medicine Ukgansan for clinical symptoms in Parkinson's disease: A pilot, randomized, assessor-blinded clinical trial.
    Jin C; Cho KH; Kwon S; Lee HG; Kim TH; Jung WS; Moon SK; Cho SY; Kang BK; Park JM; Park HJ; Ko CN
    Front Neurol; 2022; 13():1025269. PubMed ID: 36438946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLP-1 receptor agonists for Parkinson's disease.
    Mulvaney CA; Duarte GS; Handley J; Evans DJ; Menon S; Wyse R; Emsley HC
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012990. PubMed ID: 32700772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.
    Parashos SA; Luo S; Biglan KM; Bodis-Wollner I; He B; Liang GS; Ross GW; Tilley BC; Shulman LM;
    JAMA Neurol; 2014 Jun; 71(6):710-6. PubMed ID: 24711047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of Myofascial-meridian Release Acupuncture (MMRA) for chronic neck pain: a study protocol for randomized, patient- and assessor-blinded, sham controlled trial.
    Lee S; Nam D; Leem J; Han G; Lee S; Lee J
    BMC Complement Altern Med; 2016 Feb; 16():45. PubMed ID: 26833397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial.
    Chaudhuri KR; Odin P; Ferreira JJ; Antonini A; Rascol O; Kurtis MM; Storch A; Bannister K; Soares-da-Silva P; Costa R; Magalhães D; Rocha JF
    BMC Neurol; 2022 Mar; 22(1):88. PubMed ID: 35279112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial.
    van der Kolk NM; de Vries NM; Kessels RPC; Joosten H; Zwinderman AH; Post B; Bloem BR
    Lancet Neurol; 2019 Nov; 18(11):998-1008. PubMed ID: 31521532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of the Park-in-Shape study: a phase II double blind randomized controlled trial evaluating the effects of exercise on motor and non-motor symptoms in Parkinson's disease.
    van der Kolk NM; Overeem S; de Vries NM; Kessels RP; Donders R; Brouwer M; Berg D; Post B; Bloem BR
    BMC Neurol; 2015 Apr; 15():56. PubMed ID: 25880966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of yoga versus stretching and resistance training exercises on psychological distress for people with mild-to-moderate Parkinson's disease: study prxotocol for a randomized controlled trial.
    Kwok JYY; Kwan JCY; Auyeung M; Mok VCT; Chan HYL
    Trials; 2017 Nov; 18(1):509. PubMed ID: 29096672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.